Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 June;76(6) > Minerva Anestesiologica 2010 June;76(6):405-12



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,134

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596

Minerva Anestesiologica 2010 June;76(6):405-12



Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis

Zagli G. 1, Bonizzoli M. 1, Spina R. 1, Cianchi G. 1, Pasquini A. 1, Anichini V. 1, Matano S. 1, Tarantini F. 2, Di Filippo A. 2, Maggi E. 3, Peris A. 1

1 Intensive Care Unit of Emergency Department, Careggi Teaching Hospital and University of Florence, Florence, Italy
2 Department of Critical Care Medicine and Surgery, Careggi Teaching Hospital and University of Florence, Florence, Italy
3 Department of Internal Medicine, University of Florence, Florence, Italy

AIM: The beneficial role of hemofiltration with immobilized polymyxin-B fiber (PMX) columns in sepsis, especially sepsis due to gram-negative bacteria, has previously been emphasized. Although the efficacy of PMX-B fiber-mediated hemofiltration in reducing plasma levels of cytokines has been reported, other studies did not confirm this observation. Here we report the effects of PMX-B fiber-mediated hemofiltration on outcome and cytokine plasma levels in patients with abdominal sepsis.
METHODS: Twelve consecutive patients admitted to the Intensive Care Unit (October 2006-December 2007) for severe sepsis/septic shock from abdominal infection were treated with standard therapy and 2 cycles of hemofiltration with PMX cartridges. Clinical data and plasma levels of IL-6, IL-10 and TNF-a were measured 24 hours before and after PMX treatment.
RESULTS: Plasma concentrations (pg/mL) of IL-6, IL-10 and TNF-a were significantly lower after hemofiltration with a PMX fiber column (279.9±69.2 vs. 130.9±18.4, 166.4±36.7 vs. 45.5±12.2, 83.1±13.5 vs. 23.9±5.1 pg/mL, respectively; P<0.05). After treatment, patients required lower doses of norepinephrine (0.3±0.1 vs. 0.8±0.1 mg/kg/min) and reduced lactate levels, recovery of respiratory function and improved Simplified Organ Failure Assessment (SOFA) scores. After 28 days, 6 patients (50%) had survived. Subgroup analysis demonstrated that survivors had higher IL-6 and lower IL-10 and TNF-a pre-treatment plasma levels (pg/mL) compared with deceased patients (324.4±41.1 vs.235.3±38.4; 98.5±16.1 vs. 234.3±48.6, 44.5±9.0 vs.121.6±52.3 pg/mL, respectively; P<0.05). No adverse events imputable to the treatment were recorded.
CONCLUSION: Hemofiltration with a PMX fiber column was able to reduce plasma levels of IL-6, IL-10 and TNF-a, especially in patients surviving at 28 days. Use of the technique was associated with lower norepinephrine support and an increased PaO2/FiO2 ratio.

language: English


top of page